US11980736B2 - Infusion pump flow rate control - Google Patents
Infusion pump flow rate control Download PDFInfo
- Publication number
- US11980736B2 US11980736B2 US17/321,348 US202117321348A US11980736B2 US 11980736 B2 US11980736 B2 US 11980736B2 US 202117321348 A US202117321348 A US 202117321348A US 11980736 B2 US11980736 B2 US 11980736B2
- Authority
- US
- United States
- Prior art keywords
- tube
- fluid
- flow rate
- infusion pump
- implementations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 238000001802 infusion Methods 0.000 title claims abstract description 99
- 239000012530 fluid Substances 0.000 claims abstract description 205
- 238000000034 method Methods 0.000 claims abstract description 42
- 238000005381 potential energy Methods 0.000 claims abstract description 39
- 230000008859 change Effects 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 13
- 238000011144 upstream manufacturing Methods 0.000 claims description 10
- 239000002356 single layer Substances 0.000 claims description 8
- 239000000356 contaminant Substances 0.000 claims description 6
- 239000007933 dermal patch Substances 0.000 claims description 4
- 239000011324 bead Substances 0.000 description 58
- 239000003814 drug Substances 0.000 description 24
- 238000003860 storage Methods 0.000 description 20
- 239000000463 material Substances 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 13
- 238000004891 communication Methods 0.000 description 9
- 238000013461 design Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000013536 elastomeric material Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 101000741396 Chlamydia muridarum (strain MoPn / Nigg) Probable oxidoreductase TC_0900 Proteins 0.000 description 1
- 101000741399 Chlamydia pneumoniae Probable oxidoreductase CPn_0761/CP_1111/CPj0761/CpB0789 Proteins 0.000 description 1
- 101000741400 Chlamydia trachomatis (strain D/UW-3/Cx) Probable oxidoreductase CT_610 Proteins 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920005644 polyethylene terephthalate glycol copolymer Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/148—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags
- A61M5/152—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags pressurised by contraction of elastic reservoirs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/08—Tubes; Storage means specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/165—Filtering accessories, e.g. blood filters, filters for infusion liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16804—Flow controllers
- A61M5/16813—Flow controllers by controlling the degree of opening of the flow line
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16877—Adjusting flow; Devices for setting a flow rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16877—Adjusting flow; Devices for setting a flow rate
- A61M5/16881—Regulating valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M2005/1401—Functional features
- A61M2005/1405—Patient controlled analgesia [PCA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
- A61M2005/14252—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
Definitions
- the present disclosure pertains to fluid pumps. More particularly, portable infusion pumps which are useful for pumping relatively small amounts of fluids under substantially constant pressure at accurate and constant flow rates over a sustained period of time.
- the present invention is particularly, but not exclusively, useful for a one-time use as a disposable pump for infusing fluid medicaments to an ambulatory patient.
- an infusion pump includes a housing.
- the housing includes an elastic component configured to expand and store potential energy generated by the fluid within the infusion pump.
- the infusion pump includes a first tube fluidically coupled to an outlet of the housing.
- the first tube is configured to conduct the fluid from the housing at a first flow rate based, in part, on the potential energy stored by the elastic component.
- the infusion pump includes an air filter fluidically coupled to a distal end of the first tube via an air filter inlet.
- the air filter configured to expel air from the fluid, via one or more air vents, substantially upstream such that the fluid exiting the air filter is primed without air.
- the infusion pump includes a second tube fluidically coupled to the air filter via an air filter outlet that is configured to adjust the first flow rate of the fluid conducted from the housing, via the first tube, to a second flow rate.
- the second flow rate is based, at least in part, on an inner diameter of the second tub.
- the infusion pump further includes an outlet of the second tube fluidically coupled to one or more components for distributing the fluid to a user.
- a method of infusing fluid to a patient is performed at an infusion pump.
- the infusion pump includes a housing that includes an elastic component, a first tube fluidically coupled to the housing, via an outlet of the housing, an air filter fluidically coupled to a distal end of the first tube via an air filter inlet, a second tube fluidically coupled to the air filter via an air filter outlet, and an outlet of the second tube fluidically coupled to one or more components.
- the method performed at the infusion pump includes expanding the elastic component with the fluid to store potential energy generated by the fluid within the infusion pump; conducting, from the first tube, fluid from the housing at a first flow rate based, in part, on the potential energy stored by the elastic component; expelling air from the fluid via the one or more air vents of the air filter, where the air is expelled substantially upstream such that the fluid exiting the air filter is primed without air; adjusting the first flow rate of the fluid conducted from the housing, via the first tube, to a second flow rate, the second flow rate based, at least in part, on an inner diameter of the second tube; and distributing the fluid to a user via the one or more components coupled to the outlet of the second tube.
- FIG. 1 illustrates a disposable infusion pump, in accordance with some implementations.
- FIG. 2 illustrates a disposable infusion pump, in accordance with some implementations.
- FIG. 3 is an overview of the disposable pump system, in accordance with some implementations.
- FIGS. 4 A and 4 B illustrate cross sectional views of the disposable pump, in accordance with some implementations.
- FIGS. 5 A and 5 B illustrate a flow restrictor component, in accordance with some implementations.
- FIGS. 6 A and 6 B illustrate another flow restrictor component, in accordance with some implementations.
- FIG. 7 is a block diagram depicting a flow controller, in accordance with some implementations.
- FIGS. 8 A- 8 D are flowcharts illustrating a method for controlling the flow rate of the disposable pump, according to some implementations
- Implementations as disclosed herein include an infusion pump and infusion methods for infusing a user with fluid medicament.
- the infusion pump is coupled to a user and configured to provide the fluid medicament to the user with an accurate and constant flow rate. Accordingly, implementations as disclosed herein provide different devices and/or techniques for controlling and/or adjusting the flow rate of the fluid medicament.
- the infusion pump and infusion methods facilitate the safe infusion of fluid medicament.
- Some additional advantages of the implementations consistent with the present disclosure include precise control of the flow rates and lower achievable flow rates for fluid medicament distributed to a user.
- the infusion pump can be designed to produce the desired flow rate and, if needed, can finely tune the flow rate as needed.
- the infusion pump and the infusion methods allow for great flexibility in achieving different flow rates by using one or more of the techniques and/or devices disclosed herein. Implementations as disclosed herein are suitable for a variety of fluid medicaments and/or applications (e.g., chemotherapy administration, antibiotic administration, pain management, etc.). Accordingly, improving the flexibility in adjusting the flow rates and/or increasing the number of applications of the infusible pumps reduces the total costs by provided an affordable alternative for fluid medicament infusion that is functional across a variety of applications.
- FIG. 1 illustrates a disposable infusion pump in accordance with some implementations.
- the disposable pump 100 (also referred to herein as an infusion pump) may be worn by a user 102 during ambulation and can be attached to the user 102 by holder 104 .
- the holder 104 can be a belt, a fanny pack, a lanyard, a backpack, a pouch, and/or other device for carrying the disposable pump 100 .
- FIG. 1 shows that the disposable infusion pump 100 can be fluidically coupled to the user 102 for the infusion of fluids into the user 102 through a first medical tubing 106 .
- the fluid can be water or any fluid medicament such as chemotherapy drugs, pain drugs, prescription drugs, saline, etc.
- the first medical tubing 106 can be any type of IV tubing for infusion tubing, such as air filtered micro-bore IV tubing, small-bore IV tubing, large-bore IV tubing, and/or any other type of tubing for infusion.
- the material for the first medical tubing 106 is Tygon®, thermoplastic elastomers (TPE), polyethylene, polyvinyl chloride (PVC), nylon, silicone, and/or other similar material.
- TPE thermoplastic elastomers
- PVC polyvinyl chloride
- the Tygon material bonds to the various components of the infusion pump using a single solvent application.
- Tygon material may provide an advantage in that it can be extruded at a significantly smaller inner diameter than other types of tubing (e.g., PVC) on the pump, and improve flow rate accuracy, and may make the tubing much less sensitive to length adjustments.
- a small change in diameter accuracy may have an exponential impact on rate accuracy.
- an in-line air filter 108 is fluidically coupled to the first medical tubing 106 (via an inlet of the in-line air filter 108 ).
- the in-line air filter 108 can be a pediatric filter IV filter, a micro IV filter, and/or other suitable filters for drug delivery, chemotherapy, insulin infusion, antibiotic therapy Lipid/TPN infusion, neonatal infusion therapy, etc.
- the in-line air filter 108 is configured to remove air from the conducted fluid (e.g., leaving the disposable pump 100 ) in order to prevent the infusion of air to the user 102 .
- the in-line air filter 108 is configure to remove contaminants and/or particles from the fluid to prevent the infusion of harmful substance to the user 102 .
- the air filter is located near the disposable pump 100 (as described below) such that air is expelled from the fluid substantially upstream and the fluid exiting the air filter is primed (without air) for user 102 infusion.
- Primed means filling the medical tubing 106 with fluid so that it is ready to be infused into the user 102 .
- a second medical tubing 112 is fluidically coupled to the in-line air filter 108 (via an outlet of the in-line air filter 108 ).
- the first medical tubing 106 and the second medical tubing 112 are the same (e.g., same type of tubing (e.g., material), size (e.g., inner and outer diameter) of tubing, length of tubing, etc.).
- the first medical tubing 106 and the second medical tubing 112 are distinct (e.g., with one or more variations in the type of tubing, size (e.g., inner and/or outer diameter) of tubing, length of tubing, etc.).
- the first medical tubing 106 and the second medical tubing 112 are discussed in further detail below with reference to FIGS. 4 A- 4 B .
- an external flow restrictor 110 is coupled to the first medical tubing 106 (e.g., via an exterior portion of the first medical tubing 106 ) to provide and/or remove an external pressure to the first medical tubing 106 .
- the external pressure to the first medical tubing 106 is configured to close or open a fluid passageway of the first medical tubing 106 (e.g., stop or start the flow of fluid from the pump 100 by applying enough pressure to the first medical tubing 106 to act as a shut-off valve).
- the external flow control 110 can be a slide clamp, a pinch clamp, a roller clamp, a screw clamp, and/or any other type of device capable of initiating or terminating the flow of fluid from the disposable pump 100 .
- FIG. 2 illustrates an overview of the disposable infusion pump 100 in accordance with some implementations.
- the disposable pump 100 includes a housing 200 , which is an assembly of a first portion 202 and a second portion 204 .
- the first portion 202 includes a first surface 402 a (e.g., an exterior or upper surface; shown in FIG. 4 ) and a second surface 402 b directly opposite the first surface (e.g., an internal or bottom surface (when the first portion 202 and the second portion 204 are coupled); shown in FIG. 4 ).
- the first surface of the first portion 202 includes an inlet 208 and an outlet 210 for receiving and distributing fluids, respectively.
- the second surface includes an elastic component 206 coupled between a first ring 410 and a second ring 414 (shown in FIG. 4 ).
- the first and second rings are affixed to the second surface.
- the first ring is affixed to the second surface via, edges 404 of the first portion (e.g., shown in FIG. 4 ).
- the elastic component 206 is configured to expand and store potential energy generated by the fluid within the infusion pump.
- the first medical tubing 106 is coupled to the outlet 210 (on the first surface) of first portion 202 such that fluid can be distributed from the disposable pump 100 (when loaded with fluid as described below in reference to FIG. 4 ).
- FIG. 3 is an overview of a pump system in accordance with some implementations.
- the first portion 202 (including a first 402 a and second 402 b surface; shown in FIG. 4 ) of housing 200 is made of a hard plastic, such as polycarbonate and/or other materials that are chemically compatible with the fluid to be infused to the user 102 .
- the first portion 202 has a parabolic (or dome/diaphragm shape) with the second surface 402 b extending in a direction opposite first surface 402 a (e.g., the first surface being indented slightly).
- the first portion 202 is configured to stretch the elastic component 206 (via the second surface 402 b ) into a similar shape when assembled (e.g., as shown in FIGS. 4 A and 4 B ).
- the second surface 402 b of the first portion 202 defines the shape of the elastic component 206 (e.g., while storing potential energy or not).
- edges 404 of the first portion 202 extend outwardly from the second surface 402 b to provide a surface to couple the elastic component 206 onto the first portion 202 (e.g., via the upper 410 and lower 414 rings as described below).
- the first portion 202 of housing 200 can be manufactured using injection molding, urethane casting, 3D molding, and/or other manufacturing procedures.
- a valve sleeve 406 and a valve insert 408 are inserted into inlet 208 (e.g., the valve sleeve 406 and the valve insert 408 shown in FIG. 4 ).
- the sleeve 406 and valve insert 408 When inserted into inlet 208 , the sleeve 406 and valve insert 408 generate a one-way valve for the first portion 202 of housing 200 that permits the flow of fluid in one direction (e.g., externally through the inlet 208 ).
- An important aspect of the disposable pump 100 is to be able to fill the disposable pump 100 with fluid through the inlet 208 and to secure the fluid such that the fluid is not able to leave the disposable pump 100 (e.g., exit through the inlet 208 and/or other portions of housing 200 ).
- a fluid is loaded into the inlet 208 under pressure utilizing a syringe (not shown) or other device for injecting a fluid.
- the disposable pump 100 includes at least two retainer rings (e.g., an upper ring 410 and a lower ring 414 ).
- the upper ring 410 is engaged with a rib 412 that defines the elastic component 206 (e.g., rib 412 shown in FIG. 4 ).
- the upper ring 410 is also configured to be engaged with the lower ring 414 effectively coupling the rib 412 of the elastic member 206 between the upper ring 410 and lower ring 414 .
- the upper ring 410 and the lower ring 414 can be of any suitable rigid material such as polycarbonate.
- the upper ring 410 and the lower ring 414 when joined together support the elastic component 206 , and provide a firm foundation for the elastic component 206 to expand and store potential energy as described below with respect to FIGS. 4 A and 4 B .
- the elastic component 206 is a substantially circular and planar when it is not expanded (e.g., in a relaxed and/or unstretched state).
- rib 412 defines the shape of the elastic component 206 (e.g., in a relaxed or pressurized state) and is configured to be coupled between the upper ring 410 and lower ring 414 .
- elastic component 206 is composed of multiple layers of elastomeric material with at least one layer of multiple layers acting as a drug barrier. The multiple layers of the elastic component 206 are used to hold the fluid medicament.
- a drug barrier is a layer that protects the fluid (held by the multiple layers of the elastic component 206 ) from contamination from other layers or the multiple layers.
- the drug barrier does not always prevent chemical leaching that occurred because of the material of the other layers of the multiple layers. Chemical leeching is the movement of contaminants and/or other water-soluble particulates into the fluid medicament.
- the material of the elastomeric material include natural rubber, isoprene, silicon and/or other material having a high elastic memory (e.g., material that is able to expand and is naturally or automatically configured to return to its relaxed state).
- the elastic component 206 is composed of a single layer.
- the single layer is liquid injection molded silicone.
- the elastomeric material of the elastic component 206 is uniform thickness.
- the elastomeric material of the elastic component 206 can include a thickness that varies across the elastic component 206 (so long as the elastic component 206 is able to expand and store potential energy). The varying thickness can strengthen portions of the elastic component 206 experiencing larger loads (e.g., higher loads on edges of the elastic component 206 , near the rib 412 , when fluid is loaded in disposable pump 100 ).
- disposable pump 100 includes a second portion 204 of housing 200 .
- the second portion 204 can be ajar, a bottle, and/or any other container with a shape that has an opening for receiving the first portion 202 of housing 200 including the elastic component 206 .
- the second portion 204 is made of a hard or semi-rigid plastic, such as a PETG, that can be manufactured with processes such as blow molding and/or similar processes.
- the second portion 204 is made of glass.
- the elastic component 206 and disposable pump 100 can be of various sizes, and the second portion 204 can be sized accordingly.
- the second portion 204 can have an opening 416 large enough to fit the elastic component 206 and/or other components described herein, such as the at least two retainer rings.
- the second portion 204 is configured to contain (e.g., enclose) the elastic component 206 when fully expanded.
- the size for second portion 204 can be made compatible with the proposed maximum fluid capacity for the disposable pump 100 (as discussed below).
- fluid e.g., fluid medicament
- fluid that is loaded into the disposable pump 100 via the inlet 208 is configured to deliver from outlet 210 via the first medical tubing 106 .
- the first medical tubing 106 conducts the fluid from the housing 200 at a first flow rate.
- the first flow rate is based, at least in part, on the potential energy stored by the by the elastic component 206 when it is expanded by the fluid loaded into the inlet 208 (e.g., via a syringe or other similar device).
- the first flow rate is based on the inner diameter of the first medical tubing 106 , the length of the first medical tubing 106 , and/or other factors (e.g., viscosity of the fluid, temperature, changes in pressure, etc.).
- the first flow rate is configured to rapidly prime the infusion system for delivery of the fluid to the user 102 .
- the first flow rate is selected based on the second flow rate (as discussed below) to account for increase in the total time needed to prime the disposable pump 100 .
- the first flow rate can be selected to rapidly prime the disposable pump 100 while the second flow rate is configured to provide the fluid medicament to the user 102 with the appropriate (e.g., selected) flow rate.
- the first flow rate is no greater than 167 mL/hr (+/ ⁇ 0.25 mL/hr). In some implementations, the first flow rate is between the 5 mL/hr and 167 mL/hr. In some other implementations, finer control of the first flow rate is achievable reaching a flow rate less than 5 mL/hr (e.g., flow rates of about 2 mL/hr+/ ⁇ 0.25 mL/hr). In some implementations, control of the first flow rate can be achieved by adjusting the diameter and/or length of the first medical tubing 106 . Different methods of controlling the flow rate are discussed below.
- an external flow restrictor 110 is coupled to an exterior portion of the first medical tubing 106 .
- the external flow restrictor 110 is configured to provide or remove an external pressure to the first medical tubing 106 that respectively closes or opens a fluid passageway of the first medical tubing 106 .
- the external flow restrictor 110 blocks the flow of liquid medicament leaving the housing 200 (e.g., fluid leaving via outlet 210 ).
- the external flow restrictor 110 blocks the fluid passageway of the first medical tubing 106 such that fluid injected via the inlet 208 expands the elastic component 206 (e.g., the disposable pump 100 can be loaded without distributing the fluids before enough potential energy is stored).
- the elastic component 206 when expanded, stores potential energy that is used to create a pressure difference to infuse the user 102 .
- the external flow restrictor 110 or similar device is needed to create enough potential energy to ensure that the disposable pump 100 creates a substantial constant fluid pumping pressure when the elastic component 206 contracts from an expanded state to a relaxed state.
- the fluid injected into disposable pump 100 via the inlet 208 , needs to be loaded with sufficient energy to overcome the resistance of the elastic component 206 .
- a medical syringe and/or any other tool for injecting fluid can be used to overcome the resistance of the elastic component 206 . Additional information about the elastic component 206 is discussed below in FIGS. 4 A and 4 B .
- an in-line air filter 108 is included in the infusion system.
- the air filter 108 is fluidically coupled to a distal end of the first medical tubing 106 (e.g., the end of the first medical tubing 106 opposite the outlet 210 ), via an air filter inlet.
- the air filter 108 is located substantially upstream near the outlet 210 .
- the air filter 108 configured to expel air from the fluid via one or more air vents. The air is expelled substantially upstream such that the fluid exiting the air filter 108 is primed without air.
- the air filter 108 includes a membrane filter that is configured to remove one or more contaminants and particulates from the fluid.
- second medical tubing 112 is fluidically coupled to the air filter 108 via an air filter outlet.
- the second medical tubing 112 is configured to adjust the first flow rate of the fluid conducted from the housing 200 , via the first medical tubing 106 , to a second flow rate.
- the second flow rate based, at least in part, on an inner diameter of the second medical tubing 112 .
- the second flow rate is based on the length of the first medical tubing 106 , and/or other factors (e.g., viscosity of the fluid, temperature, changes in pressure, etc.).
- the first flow rate and the second flow rate are selected to quickly prime disposable pump 100 .
- the first flow rate may be selected to be significantly higher than the second flow rate such that the disposable device is substantially primed leaving only a smaller portion of the disposable pump 100 to be primed (e.g., the first flow rate may prime 3 ⁇ 4 of the disposable pump 100 (such as the length of the first medical tubing 106 and air filter 108 ) leaving only 1 ⁇ 4 to be primed at the second flow rate (such as the length of the second medical tubing 112 )).
- the second flow rate is no greater than 5 mL/hr. In some implementations, the second flow rate is between the 2 mL/hr and 5 mL/hr.
- the second flow rate is about 2 mL/hr (e.g., about being +/ ⁇ 0.25 mL/hr). In some implementations finer control of the second flow rate (e.g., lower than 2 mL/hr) can be achieved by adjusting the diameter and/or length of the second medical tubing 112 . In some implementations, the inner diameter of the second medical tubing 112 is no greater than 0.0075 inches. In some implementations, the second medical tubing 112 is a predetermined length that is dependent on the targeted flow rate (e.g., a longer length generates a slower flow rate). In some embodiments, the second medical tubing 112 is used adjust the flow rate of the fluid medicament before it is distributed to the user 102 .
- the inner diameter of the first medical tubing 106 and the inner diameter of the second medical tubing 112 can be the same or distinct.
- the length, the material, and/or other parameters of the first medical tubing 106 and the second medical tubing 112 can be the same or distinct.
- the parameters for the first medical tubing 106 and the second medical tubing 112 depend on the flow rate that needed to infuse the user 102 .
- the second medical tubing 112 is used to achieve the desired flow rate before the fluid is infused to user 102 .
- an outlet 302 of the second medical tubing 112 (e.g., a distal outlet) is fluidically coupled to the second medical tubing 112 .
- the outlet 302 of the second medical tubing 112 is configured connect with one or more components for distributing the fluid to a user 102 .
- the outlet 302 of the second medical tubing 112 is a fixed male luer.
- the one or more components configured to connect with the outlet 302 of the second medical tubing 112 include a skin patch, a needle, a cannula, and a catheter and/or other components for infusing the user 102 .
- a flow restrictor component is placed within the first medical tubing 106 and/or the second medical tubing 112 .
- the flow restrictor component can be located at a first location 304 a within the first medical tubing 106 and/or at a second location 304 b within the second medical tubing 112 .
- the flow restrictor can be placed at each location (e.g., the first 304 a and second 304 b location). The flow restrictor component can be placed at any location within the first medical tubing 106 and/or the second medical tubing 112 .
- the flow restrictor component can be placed adjacent to the outlet 210 of the housing 200 (e.g., within the first medical tubing 106 ), adjacent to an outlet 302 of the second medical tubing 112 , adjacent to the inlet or outlet of the air filter 108 , and/or anywhere in between.
- the flow restrictor component is unfixed and configured move freely along the first medical tubing 106 and/or the second medical tubing 112 .
- the flow restrictor component is fixed (anchored or fastened) at a particular location of the first medical tubing 106 and/or the second medical tubing 112 (e.g., such that the flow restrictor component does not move).
- the flow restrictor component is independent of the flow control provided by the first medical tubing 106 and/or the second medical tubing 112 .
- the flow restrictor component includes one or more pins and/or beads as described below in FIGS. 5 A- 6 B .
- the flow restrictor component has a diameter less than an inner diameter of the first medical tubing 106 and/or the second medical tubing 112 .
- the flow restrictor component has a diameter greater than the inlet and/or outlet of the air filter 108 such that the flow restrictor component stays within a particular location or portion of the tube (e.g., within the first medical tubing 106 or the second medical tubing 112 ).
- the flow restrictor component has a diameter greater than the outlet 302 of the second medical tubing 112 such that the flow restrictor component does not flow into the user 102 . Further, the flow restrictor component is configured not to break or come apart as a user moves the first medical tubing 106 and/or the second medical tubing 112 . The flow restrictor component is discussed in more detail in FIGS. 5 and 6 .
- the disposable pump 100 includes a controller chip (not shown) configured to operate a valve to control the first flow rate and/or the second flow rate of the fluid.
- the controller chip is discussed below in FIG. 7 .
- the controller chip is a discrete component fluidically coupled i-line with one or more components of the disposable pump 100 .
- the controller chip can be fluidically coupled to the between the outlet 210 of disposable pump 100 and the first medical tubing 106 ; the first medical tubing 106 and the air filter 108 ; the air filter 108 and the second medical tubing 112 ; and/or second medical tubing 112 and the outlet 302 of the second medical tubing 112 .
- the controller chip is coupled to the housing 200 .
- the flow controller chip is discussed in more detail in reference to FIG. 7 .
- FIGS. 4 A and 4 B illustrate cross sectional views of the disposable pump 100 , in accordance with some implementations. More specifically, FIGS. 4 A and 4 B illustrate the expansion of the elastic component 206 as fluid is introduced through the inlet 208 of housing 200 and into the fluid storage 420 (which stores potential energy generated by expanded elastic component 206 ) under the pressure of a syringe, or some other tool for pumping a fluid. In some implementations, air in the system is removed (e.g., vented) via outlet 210 along the indentation 422 , which is formed based on the second surface 402 b.
- FIG. 4 A shows upper ring 410 coupled with lower ring 414 , and rib 412 coupled in between the two.
- rib 412 defines the shape of elastic component 206 .
- the upper ring 410 and lower ring 414 are coupled by ultrasonic welding and/or solvent bonding.
- the upper ring 410 is coupled to the first portion 202 (e.g., via edges 404 ) and the lower ring 414 is coupled to the second portion 204 using ultrasonic welding or solvent bonding.
- the elastic component 206 is positioned across the opening 416 of second portion 204 and creates cavity 418 (e.g., a space created within housing 200 ).
- the second surface 402 b of the first portion 202 stretches elastic component 206 in the shape of the second surface 402 b (e.g., as shown in FIG. 4 ).
- the dimensions of both the elastic component 206 and the second surface 402 b are such that the elastic component 206 is stretched to a state where its elasticity does not behave in a linear fashion.
- the elastic component 206 is stretched to a state where changes in the stress of the material of the elastic component 206 are not linearly proportional to changes in the strain of the material during the operation of the disposable pump 100 .
- FIG. 4 B show a cross section view of disposable pump 100 after fluid has been injected via inlet 208 of the first portion 202 of housing 200 , in accordance with some implementations.
- the injected fluid expands elastic component 206 to create expanded fluid storage 420 .
- Expanded fluid storage 420 is under the pressure of a syringe and/or other too that is used to inject fluid (via inlet 208 ) into disposable pump 100 (after air has been removed from the system via the outlet (via inlet 210 ) along the indentation 422 , which is formed based on the second surface 402 b .
- an external flow restrictor 110 can be used to block a fluid passageway of the first medical tubing 106 such that fluid does not leave outlet 210 allowing for the fluid storage 420 to expand as fluid is injected into the disposable pump 100 .
- the expansion and subsequent contraction of elastic component 206 is achieved when, before fluid is injected in inlet 208 , the elastic component 206 is stretched to a state where its elasticity is nonlinear. As mentioned above, this state is achieved by the shape and/or dimensions of the second surface 402 b and/or the elastic component 206 during assembly of the housing 200 .
- the medical syringe (not shown) and/or any other tool used to inject fluid into the disposable pump 100 must inject the fluid with enough force to overcome the current state the elastic component 206 (e.g., enough force to overcome the force generated by the elastic component 206 to contract).
- the elastic component 206 must be stretched non-linearly to form and expand the fluid storage 420 as shown in FIG. 4 B .
- the fluid storage 420 is configured to expand to hold a volume of at least 50 mL of fluid. In some other implementations, the fluid storage 420 is configured to expand to hold a volume of at least 100 mL of fluid. In yet other implementations, the fluid storage 420 is configured to expand to hold a volume of at least 250 mL of fluid.
- a fluid In general, a fluid must be introduced under a pressure sufficient to overcome the potential energy of the initially stretched elastic component 206 (stretched by the second surface 402 b ). Similarly, a fluid must be introduced under a pressure that is sufficient to further stretch (non-linearly) the elastic component 206 and form the fluid storage 420 .
- the potential energy stored by the fluid storage 420 is the total amount of energy available for discharging the fluid (e.g., out of outlet 210 ). The fluid storage 420 , even after fully discharging the fluid, has residual potential energy due to the elastic component 206 being stretch over the second surface 402 b.
- the flow of fluid through the first medical tubing 106 and/or the second medical tubing 112 can be characterized by the Hagen-Poiseuille equation.
- the flow can be characterized by the Hagen-Poiseuille equation because it is assumed that the flow through the first medical tubing 106 and/or the second medical tubing 112 is laminar flow.
- the pressure generated by the disposable pump 100 P_device
- the pressure generated by the patient P_patient
- V ⁇ ⁇ p ⁇ ⁇ ⁇ D 4 1 ⁇ 2 ⁇ 8 ⁇ ⁇ ⁇ L , where:
- a constant flow rate of fluid through a tube can be achieved (e.g., by designing the first medical tubing 106 and/or the second medical tubing 112 as described herein). It can be assumed that there is constant energy loss over the length of a tube (e.g., the first medical tubing 106 and/or the second medical tubing 112 ) because, as mentioned above, P_device and P_patient are considered to be constant. As a practical matter, P_patient is negligibly small. As such, the flow of disposable pump 100 is due almost entirely to the constant pressure produced by the stored potential energy of the elastic member 206 .
- the P_device and the physical design of the first medical tubing 106 and/or the second medical tubing 112 must be consideration together.
- the pressure held by the elastic component 206 e.g., stored potential energy
- the respective diameter and/or length of the first medical tubing 106 and/or the second medical tubing 112 is used along with the respective diameter and/or length of the first medical tubing 106 and/or the second medical tubing 112 to determine the flow rate for the disposable pump 100 .
- FIGS. 5 A and 5 B illustrate a flow restrictor component in accordance with some implementations.
- a tube segment 502 e.g., either the first medical tubing 106 and/or the second medical tubing 112
- a flow restrictor component such as a pin 506
- the pin 506 has a diameter less than the inner diameter of the tube segment 502 such that the pin 506 can be located within the tube segment 502 .
- the pin 506 has a diameter greater than the inlet and/or outlet of the air filter 108 and/or the outlet 302 of the second medical tubing 112 .
- the pin 506 remains within the tube segment 502 without moving between different tube segments (e.g., from the first medical tubing 106 to the second medical tubing 112 and vice versa) and/or to prevent the pin 506 from being infused to user 102 .
- the pin 506 is fixed (anchored at a particular location) or unfixed (moveable along a length) within the tube segment 502 .
- the pin 506 has a predetermined length.
- the pin 506 is made of glass or metal.
- the pin 506 is configured to adjust (e.g., decrease) the flow rate (e.g., either the first flow rate or the second flow rate as discussed above in FIG. 3 ). In some implementations, adjustment of the flow rate is based, in part, on the diameter of the pin 506 . In some implementations, the pin 506 is configured to change the shape of the fluid from a cylindrical shape (e.g., cylindrical flow 504 ) to a torus shape (e.g., doughnut or torus flow 508 ). For example, as show in FIG. 5 A , the pin 506 changes the cylindrical flow 504 to a torus flow 508 where the radius of the torus flow 508 is based, in part, on the diameter of the pin 506 .
- a cylindrical shape e.g., cylindrical flow 504
- a torus shape e.g., doughnut or torus flow 508
- torus flow 508 is shown as a single ring, it should be noted that torus flow 508 is a continuous stream (as shown in FIG. 5 B ).
- the change in the flow rate shape decreases the flow rate by disrupting the flow and having the flow move around the pin 506 (e.g., without causing the tube segment 502 to expand or change shape).
- the flow rate is further based, in part, on the predetermined length of the pin 506 .
- FIG. 5 B shows a partial cross-sectional side view of the flow restrictor component in FIG. 5 A .
- cylindrical flow 504 flows from the disposable pump 100 (e.g., via outlet 210 ) towards the distal end (end opposite outlet 210 of disposable pump 100 ) of the tube segment 502 .
- the pin 506 reduces the flow rate of the cylindrical flow 504 by reducing the cross sectional area of the cylindrical flow 504 by the cross sectional area of the pin 506 , and, thus, changing the flow to a torus flow 508 .
- the area of the cylindrical area of the tube segment 502 is reduced by the cross sectional area of the pin 506 .
- the pin 506 generates an annular section (e.g., the length of pin 506 ) within the tube segment 502 .
- the flow within the annular section of the tube segment 502 follows the following Poiseuille equation:
- a constant flow rate of fluid through a tube segment 502 with pin 506 can be achieved (e.g., by designing the first medical tubing 106 , the second medical tubing 112 , and/or the pin 506 as described herein).
- the P_device and the physical design of the first medical tubing 106 , the second medical tubing 112 , and/or the pin 506 must be consideration together.
- the pressure held by the elastic component 206 e.g., stored potential energy
- the pressure held by the elastic component 206 is used along with the respective diameter of the first medical tubing 106 , the second medical tubing 112 , and/or the pin 506 to determine the flow rate for the disposable pump 100 .
- P_patient is negligibly small. As such, the flow of disposable pump 100 is due almost entirely to the constant pressure produced by the stored potential energy of the elastic member 206 .
- FIGS. 6 A and 6 B illustrate another flow restrictor component in accordance with some implementations.
- a tube segment 502 e.g., either the first medical tubing 106 and/or the second medical tubing 112
- another flow restrictor component such as one or more rigid beads 602
- the one or more rigid beads 602 have a diameter less than the inner diameter of the tube segment 502 such that the one or more rigid beads 602 can be located within the tube segment 502 .
- the one or more rigid beads 602 have a diameter greater than the inlet and/or outlet of the air filter 108 and/or the outlet 302 of the second medical tubing 112 . In this way, the one or more rigid beads 602 remain within the tube segment 502 without moving between different tube segments (e.g., from the first medical tubing 106 to the second medical tubing 112 and vice versa) and/or to prevent the one or more rigid beads 602 from being infused to user 102 .
- the one or more rigid beads 602 are fixed (anchored) or unfixed (moveable) within the tube segment 502 .
- each rigid bead of the one or more rigid beads 602 is the same.
- at least one rigid bead (or all) of the one or more rigid beads 602 can be distinct carrying in size (e.g., the one or more rigid beads 602 have varying diameters).
- the rigid beads 602 may be made of glass or metal. According to various aspects, the rigid beads may be sized so that placement of the rigid beads does not cause the tubing (e.g., tube segment 502 ) to expand. As mentioned above, in some implementations, the one or more rigid beads 602 have a diameter less than the inner dimeter of the tube segment 502 .
- a flow rate through tubing segment may be defined, at least in part, by a function of the cross-sectional area or diameter of the bead(s) within the tubing, the difference between the cross-sectional area or diameter of the bead and the inner diameter of the tubing, and/or the number of the beads within the tubing or their collective mass within a predetermined area of the tube segment 502 .
- the one or more rigid beads 602 are configured to adjust (e.g., decrease) the flow rate (e.g., either the first flow rate or the second flow rate as discussed above in FIG. 3 ). In some implementations, adjustment of the flow rate is based, in part, on the diameter of the one or more rigid beads 602 .
- the one or more rigid beads 602 are configured to have the fluid (e.g., cylindrical flow 504 ) move around their surface or diameter (e.g., without causing the tube segment 502 to expand or change shape).
- the flow rate is based, in part, on the diameter of the one or more rigid beads (e.g., the area that the fluid needs to move around). In some implementations, the flow rate is further based on the number of one or more rigid beads 602 within the tube segment 502 (e.g., each rigid bead of the one or more rigid beads 602 decreasing the flow rate).
- FIG. 6 B shows a partial cross-sectional side view of the flow restrictor component in FIG. 6 A .
- at least two rigid beads of the one or more rigid beads 602 are within the tube segment 502 .
- Further shown in FIG. 6 B is cylindrical flow 504 flowing from the disposable pump 100 (e.g., via outlet 210 ) towards the distal end (end opposite outlet 210 of disposable pump 100 ) of the tube segment 502 .
- the one or more rigid beads 602 reduce the flow rate of the cylindrical flow 504 by reducing the cross sectional area of the cylindrical flow 504 by the cross sectional area of the one or more rigid beads 602 .
- the area of the cylindrical area of the tube segment 502 is reduced by the cross sectional area of the one or more rigid beads 602 .
- the flow within the tube segment 502 with the one or more rigid beads 602 follows the Poiseuille equations as described above (e.g., derived for the respective diameters and/or circumference of the one or more rigid beads 602 ).
- a constant flow rate of fluid through a tube segment 502 with the one or more rigid beads 602 can be achieved (e.g. by designing the first medical tubing 106 , the second medical tubing 112 , and/or the one or more rigid beads 602 as described herein).
- the P_device and the physical design of the first medical tubing 106 , the second medical tubing 112 , and/or the one or more rigid beads 602 must be consideration together.
- the pressure held by the elastic component 206 e.g., stored potential energy
- P_patient is negligibly small. As such, the flow of disposable pump 100 is due almost entirely to the constant pressure produced by the stored potential energy of the elastic member 206 .
- the different flow restrictor components can be combined in the tube segment 502 .
- the tube segment 502 can include pin 506 and one or more rigid beads 602 .
- FIG. 7 is a block diagram depicting a flow controller 700 in accordance with some implementations.
- the disposable pump 100 includes a flow controller 700 that is configured to control the flow of fluid discharged from the disposable pump 100 .
- the flow controller 700 is coupled to the housing (e.g., via the first 202 and/or second portion 202 of the housing 200 ).
- the flow controller 700 is fluidically coupled in-line with the first medical tubing 106 , the second medical tubing 112 , and/or other components of the disposable pump 100 (e.g., between the first medical tubing 106 and the outlet 210 , the first medical tubing 106 and the air filter 108 , etc.).
- the flow controller 700 operates one or more pillows (e.g., expandable components to block a fluid passageway), a valve, and/or similar components to control the available fluid passageway of the disposable pump 100 and select a desired flow rate.
- the one or more pillows, the valve, and/or the similar components are placed adjacent (e.g., wither before or after) to the outlet 210 of disposable pump 100 .
- the flow controller 700 (including the one or more pillows, the valve, and/or the similar components) is a discrete component fluidically coupled in-line with one or more components of the disposable pump 100 (e.g., such that the fluid enters an inlet of the flow controller 700 at a first flow rate and exits an outlet of the flow controller 700 at a second flow rate selected by the user 102 ). Additionally or alternatively, in some implementations, the one or more pillows, the valve, and/or the similar components are placed with the first medical tubing 106 and/or the second medical tubing 112 .
- the flow rate controller 700 is configured to achieve a selected flow rate as low as 0.48 ml/hr.
- the flow controller 700 includes one or more processing units (including, e.g., a processor, processor core, or other type of controller chip) 702 , one or more network or other communications interfaces 704 (e.g., one or more antennas), memory 712 , one or more sensors 708 , and one or more communication buses 710 for interconnecting these components.
- the communication buses 710 optionally include circuitry (sometimes called a chipset) that interconnects and controls communications between system components.
- the flow controller 700 may include external interfaces 706 for manually controlling the flow controller 700 .
- the one or more external interfaces 706 of the flow controller 700 may include, for example, input devices such as a keyboard, a mouse, touch sensitive surfaces and/or controllers, a trackpad, USB and/or USB devices, and/or input buttons.
- the sensors 708 are used to collect data on the flow rate, the pressure held within the elastic component 206 (e.g., fluid storage 420 ), and/or other information needed to determine the flow rate of the disposable pump 100 .
- the one or more components of the flow controller 700 are sterilized to prevent contamination of the fluid medicament.
- the one or more components of the flow controller 700 are separated from the flow passageway of the disposable pump 100 (with the exception of the one or more pillows, the valve, and/or the similar components) to further prevent contamination and/or to prevent the fluid from damaging the flow controller 700 .
- the memory 712 may be a high-speed random-access memory, such as DRAM, SRAM, DDR RAM, or other random-access solid-state memory devices, and may include non-volatile memory, such as one or more magnetic disk storage devices, optical disk storage devices, flash memory devices, and/or other non-volatile solid-state storage devices.
- the memory 712 includes one or more storage devices remotely located from the processor(s) 702 .
- the memory 712 or alternatively the non-volatile memory device(s) within the memory 712 , includes a non-transitory computer-readable storage medium.
- the memory 712 or the computer-readable storage medium of the memory 712 stores programs, modules, and/or data structures that may be used for the performing one or more operations of the flow controller 700 .
- the memory 712 may include programs, modules, and/or data structures for an operating system 714 , a network communication module 716 , a flow control module 718 , and device information database 720 .
- the operating system 714 module may include procedures for handling various basic system services and for performing hardware dependent tasks.
- the network communication module 716 may be configured for connecting the flow controller 700 to other computing devices via the one or more communication network interfaces 704 (wired or wireless) and one or more communication networks, such as by Ethernet, WiFi, BLUETOOTH, an integrated services digital network (ISDN) connection, a digital subscriber line (DSL) modem or a cable modem. Any direct or indirect network connection may be used, including, but not limited to a telephone modem, an MIB system, an RS232 interface, an auxiliary interface, an optical link, an infrared link, a radio frequency link, a microwave link, a WLANS connection, or other wireless connection.
- the flow control module 718 is configured to adjust the flow rate as desired. In some implementations, the flow control module 718 determines the flow rate using the Hagen-Poiseuille equations described above. In particular, the flow control module 718 can determine the flow rate using data collected from the one or more sensors 708 and the device information database 720 . In some implementations, the flow control module 718 is configured to operate automatically (e.g., firmware designed to reach and/or maintain a desired flow rate).
- flow controller 700 and the flow control module 718 can be manually operated by a user 102 via the external interfaces 706 and/or the communications interfaces 704 (e.g., receiving wireless controls from a remote device such as a laptop, computer, mobile phone, tablet, etc.).
- the disposable pump 100 can be controlled via a dedication application.
- the device information database 720 includes data for the disposable pump 100 such as the length of the first medical tubing 106 and/or the second medical tubing 112 , the diameter of the first medical tubing 106 and/or the second medical tubing 112 , the maximum capacity of the elastic component 206 , the pressure (e.g., potential energy) stored by the elastic component 206 while loaded with different amounts of fluid, viscosity of one or more different types of fluids, and/or other useful information.
- data for the disposable pump 100 such as the length of the first medical tubing 106 and/or the second medical tubing 112 , the diameter of the first medical tubing 106 and/or the second medical tubing 112 , the maximum capacity of the elastic component 206 , the pressure (e.g., potential energy) stored by the elastic component 206 while loaded with different amounts of fluid, viscosity of one or more different types of fluids, and/or other useful information.
- FIGS. 8 A- 8 D are flowcharts illustrating a method 800 for controlling the flow rate of the disposable pump 100 according to some implementations.
- Method 800 may be performed at a disposable pump 100 , the disposable pump 100 comprising, at least, a housing 200 including an elastic component 206
- the disposable pump 100 further comprises, at least, a first tube (e.g., first medical tubing 106 ) fluidically coupled to the housing 200 via an outlet 210 ; an air filter 108 fluidically coupled to a distal end of the first tube (e.g., first medical tubing 106 ) via an air filter inlet; a second tube (e.g., second medical tubing 112 ) fluidically coupled to the air filter 108 via an air filter outlet; and an outlet 302 of the second medical tubing 112 fluidically coupled to the second tube.
- a first tube e.g., first medical tubing 106
- an air filter 108 fluidically coupled to a distal end of the first tube (e.g., first medical tub
- the housing 200 includes a first portion 202 that includes a first 402 a and second 402 b surface, the first surface 402 a includes the outlet 210 for distributing the fluid, and the second surface 402 b , opposite the first surface 402 a .
- the elastic component 206 is coupled between a first ring 410 and a second ring 414 .
- the first ring 410 and the second ring 414 is affixed to the second surface 402 b .
- the disposable pump 100 further comprises, at least, a second portion 204 that is configured to house the second surface 402 b of the first portion 202 , the first portion 202 and the second portion 204 are coupled.
- Methods consistent with the present disclosure may include at least some, but not all, of the operations illustrated in method 800 , performed in a different sequence. Furthermore, methods consistent with the present disclosure may include at least two or more steps as in method 800 performed overlapping in time, or almost simultaneously.
- the method 800 includes expanding ( 802 ) the elastic component 206 with the fluid to store potential energy generated by the fluid within the infusion pump 100 .
- the elastic component includes ( 804 ) an elastomeric membrane.
- the membrane is ( 806 ) a single layer of silicon.
- the elastic component 206 is configured to expand ( 808 ) hold a volume of at least 50 mL.
- the elastic component 206 is configured to expand ( 810 ) hold a volume of at least 100 mL.
- the elastic component 206 in configured to expand ( 812 ) hold a volume of at least 250 mL.
- the elastic component is formed of a single layer membrane and the housing 200 (of the infusion pump) includes an inlet 208 for receiving the fluid, and method 800 includes receiving ( 814 ) the fluid via the inlet; and expanding the elastic component 206 and generating the potential energy stored by the elastic component 206 based on the fluid received via the inlet.
- Method 800 includes conducting ( 816 ), from the first tube (e.g., the first medical tubing 106 ), fluid from the housing 200 at a first flow rate based, in part, on the potential energy stored by the elastic component 206 .
- the first flow rate is further based ( 818 ), at least in part, on an inner diameter of the first tube.
- the first flow rate is further based ( 820 ), at least in part, on a length of the first tube. Determinations of the flow rates are based on the potential energy stored by the elastic component 206 and the Hagen-Poiseuille equations as described above in FIGS. 4 A- 6 B .
- the infusion pump further includes ( 822 - a ) an external flow restrictor 110 coupled to an exterior portion of the first tube, and method 800 incudes, at the infusion pump, providing ( 822 - b ), via the external flow restrictor 110 , an external pressure to the first tube that closes a fluid passageway of the first tube.
- method 800 incudes removing ( 822 - c ), via the external flow restrictor 110 , the external pressure from the first tube that opens the fluid passageway of the first tube.
- the external flow restrictor 110 can be used to load (e.g., inject fluid) the elastic component 206 (e.g., expanding the elastic component 206 to create fluid storage 420 ).
- Method 800 includes expelling ( 824 ) air from the fluid via the one or more air vents of the air filter 108 .
- the air is expelled substantially upstream such that the fluid exiting the air filter is primed without air.
- the air filter includes ( 826 ) a membrane filter, and method 800 includes, at the infusion pump, removing one or more contaminants and particulates from the fluid.
- Method 800 includes adjusting ( 828 ) the first flow rate of the fluid conducted from the housing 200 , via the first tube, to a second flow rate, the second flow rate based, at least in part, on an inner diameter of the second tube (e.g., second medical tubing 112 ).
- the inner diameter of the second tube is ( 830 ) no greater than 0.0075 inches.
- the second tube is ( 832 ) a predetermined length, and the second flow rate is further based on the predetermined length.
- an inner diameter of the first tube and the inner diameter of the second tube are ( 834 ) the same.
- an inner diameter of the first tube and the inner diameter of the second tube are ( 836 ) distinct.
- the second flow rate is ( 838 ) no greater than 5 mL/hr. In some other implementations, the second flow rate is ( 840 ) about 2 mL/hr (about, in some implementations, means+/ ⁇ 0.2 mL/hr). Determinations of the flow rates are based on the potential energy stored by the elastic component 206 and the Hagen-Poiseuille equations as described above in FIGS. 4 A- 6 B .
- Method 800 includes distributing ( 842 ) the fluid to a user 102 via one or more components fluidically coupled to the outlet 302 of the second medical tubing 112 .
- the outlet 302 of the second medical tubing 112 is ( 844 ) a fixed male luer.
- the one or more components configured to connect with the outlet 302 of the second medical tubing 112 include ( 846 ) a skin patch, a needle, a cannula, and a catheter.
- the infusion pump includes ( 848 ) a flow restrictor component (e.g., pin 506 and/or rigid beads 602 ) within the first tube, the flow restrictor component having a diameter less than an inner diameter of the first tube.
- the diameter of the flow restrictor component is ( 850 ) greater than a diameter of the inlet and/or outlet of the air filter 108 , and/or the outlet 302 of the second medical tubing 112 . This way, the flow restrictor component remains within a particular tube segment and/or is not infused in user 102 (as described above in FIGS. 5 A- 6 B ).
- the flow restrictor component is ( 852 ) unfixed within the first tube.
- the flow restrictor component is ( 854 ) fixed within the first tube.
- the example provided herein has the flow restrictor component in the first tube, it should be noted that the flow restrictor component could be in the second tube and/or both the first and second tube.
- the flow restrictor component is ( 856 ) a pin 506 configured to change the shape of the fluid from a cylindrical shape (e.g., cylindrical flow 504 ) to a torus shape (e.g., torus flow 508 ).
- the pin 506 has ( 858 ) a predetermined radius, and the first flow rate is further based, in part, on the radius of the pin 506 .
- the pin 506 has ( 860 ) a predetermined length, and the first flow rate is further based, in part, on the predetermined length of the pin. The effects of the pin 506 on the flow are discussed above in reference to FIGS. 5 A and 5 B .
- the pin 506 is ( 862 ) made of glass or metal.
- the flow restrictor component is ( 864 ) one or more rigid beads that are configured to have the fluid move around a diameter of the one or more rigid beads, the first flow rate is further based, in part, on the diameter of the one or more rigid beads, and the one or more rigid beads do not cause the first tube to expand while the fluid move around the diameter of the one or more rigid beads.
- the one or more rigid beads can be ( 866 ) variable in size. In particular, all of the rigid beads can be the same (having the same diameters) or distinct (having varying diameters between rigid beads). The effects of the one or more rigid beads 602 on the flow are discussed above in reference to FIGS. 6 A and 6 B .
- at least two rigid beads are ( 868 ) included in the first tube.
- the one or more rigid beads are ( 870 ) made of glass or metal.
- the infusion pump further includes a controller chip (e.g., flow controller 700 ), and method 800 , at the infusion pump, operates ( 872 ) a valve to control the first flow rate of the fluid.
- the controller chip is controlled ( 874 ) via a USB.
- the controller chip is controlled ( 876 ) wirelessly (e.g., via wireless protocols, such as Bluetooth, or a dedicated application).
- the controller chip includes ( 878 ) firmware to automatically control the flow rate.
- the flow rate controller 700 is controlled to achieve a selected flow rate (e.g., as low as 0.48 ml/hr).
- the one or more components of the flow controller 700 e.g. wireless component 704 , the external interfaces 706 , sensors 708 , etc.
- the flow controller 700 is discussed in detail above in reference to FIG. 7 .
- An infusion pump comprising: a housing including an elastic component configured to expand and store potential energy generated by the fluid within the infusion pump, and a first tube fluidically coupled to an outlet of the housing, the first tube configured to conduct the fluid from the housing at a first flow rate based, in part, on the potential energy stored by the elastic component; an air filter fluidically coupled to a distal end of the first tube via an air filter inlet, the air filter configured to expel air from the fluid via one or more air vents, wherein the air is expelled substantially upstream such that the fluid exiting the air filter is primed without air; a second tube fluidically coupled to the air filter via an air filter outlet, wherein: the second tube configured to adjust the first flow rate of the fluid conducted from the housing, via the first tube, to a second flow rate, the second flow rate based, at least in part, on an inner diameter of the second tube, and an outlet of the second tube is configured to fluidically couple to one or more components for distributing the fluid to a user.
- Clause 2 The infusion pump of Clause 1, wherein the inner diameter of the second tube is no greater than 0.0075 inches.
- Clause 5 The infusion pump of any of Clauses 1 through 3, wherein an inner diameter of the first tube and the inner diameter of the second tube are distinct.
- Clause 6 The infusion pump of any of the proceeding Clauses, further comprising a flow restrictor component within the first tube, wherein the flow restrictor component has a diameter less than an inner diameter of the first tube.
- Clause 7 The infusion pump of Clause 6, wherein the flow restrictor component is a pin configured to change the shape of the fluid from a cylindrical shape to a torus shape, wherein: the pin has a predetermined radius, and the first flow rate is further based, in part, on the predetermined radius of the pin.
- the flow restrictor component is a pin configured to change the shape of the fluid from a cylindrical shape to a torus shape, wherein: the pin has a predetermined radius, and the first flow rate is further based, in part, on the predetermined radius of the pin.
- Clause 8 The infusion pump of any of Clauses 6 and 7, wherein the flow restrictor component is a pin configured to change the shape of the fluid from a cylindrical shape to a torus shape, wherein: the pin has a predetermined length, and the first flow rate is further based, in part, on the predetermined length of the pin.
- the flow restrictor component is a pin configured to change the shape of the fluid from a cylindrical shape to a torus shape, wherein: the pin has a predetermined length, and the first flow rate is further based, in part, on the predetermined length of the pin.
- Clause 9 The infusion pump of any of Clauses 6 through 8, wherein the flow restrictor component is one or more rigid beads that are configured to have the fluid move around a diameter of the one or more rigid beads, wherein: the first flow rate is further based, in part, on the diameter of the one or more rigid beads, and the one or more rigid beads do not cause the first tube to expand while the fluid move around the diameter of the one or more rigid beads.
- the flow restrictor component is one or more rigid beads that are configured to have the fluid move around a diameter of the one or more rigid beads, wherein: the first flow rate is further based, in part, on the diameter of the one or more rigid beads, and the one or more rigid beads do not cause the first tube to expand while the fluid move around the diameter of the one or more rigid beads.
- Clause 10 The infusion pump of Clause 9, wherein at least two rigid beads are included in the first tube.
- Clause 11 The infusion pump of any of Clauses 6 through 10, wherein the flow restrictor component is unfixed within the first tube and configured to move a length of the first tube.
- Clause 12 The infusion pump of any of Clauses 6 through 10, wherein the flow restrictor component is fixed within the first tube and configured to remain at a predetermined location of the first tube
- Clause 15 The infusion pump of any of the proceeding Clauses, further comprising an external flow restrictor coupled to an exterior portion of the first tube, the external flow restrictor configured to provide or remove an external pressure to the first tube that respectively close or open a fluid passageway of the first tube.
- Clause 16 The infusion pump of any of the proceeding Clauses, further comprising a controller chip configured to operate a valve to control the first flow rate of the fluid.
- Clause 17 The infusion pump of any of the proceeding Clauses, wherein the second flow rate such that it is no greater than 5 mL/hr.
- Clause 18 The infusion pump of any of the proceeding Clauses, wherein the one or more components configured to connect with the outlet of the second tube include a skin patch, a needle, and a catheter.
- the elastic component is formed of a single layer membrane; and the housing includes an inlet for receiving the fluid, the fluid received via the inlet expanding the elastic component and generating the potential energy stored by the elastic component.
- Clause 20 The infusion pump of Clause 19, wherein the single layer membrane is an elastomeric membrane.
- Clause 21 The infusion pump of any of the proceeding Clauses, wherein the elastic component is configured to expand to hold a volume of at least 50 mL of the fluid.
- the housing includes: a first portion that includes a first and second surface, wherein: the first surface includes the outlet of the housing for distributing the fluid, and the second surface, opposite the first surface, includes the elastic component coupled between a first ring and a second ring affixed the second surface; a second portion that is configured to house the second surface of the first portion, wherein the first portion and the second portion are coupled.
- a method of infusing fluid to a patient comprising: at an infusion pump comprising: a housing including an elastic component; a first tube fluidically coupled to the housing via an outlet of the housing, an air filter fluidically coupled to a distal end of the first tube via an air filter inlet, a second tube fluidically coupled to the air filter via an air filter outlet, and an outlet of the second tube fluidically coupled to one or more components; expanding the elastic component with the fluid to store potential energy generated by the fluid within the infusion pump; conducting, from the first tube, fluid from the housing at a first flow rate based, in part, on the potential energy stored by the elastic component; expelling air from the fluid via the one or more air vents of the air filter, wherein the air is expelled substantially upstream such that the fluid exiting the air filter is primed without air; adjusting the first flow rate of the fluid conducted from the housing, via the first tube, to a second flow rate, the second flow rate based, at least in part, on an inner diameter of the second tube
- the phrase “at least one of” preceding a series of items, with the term “and” or “or” to separate any of the items, modifies the list as a whole, rather than each member of the list (e.g., each item).
- the phrase “at least one of” does not require selection of at least one of each item listed; rather, the phrase allows a meaning that includes at least one of any one of the items, and/or at least one of any combination of the items, and/or at least one of each of the items.
- phrases “at least one of A, B, and C” or “at least one of A, B, or C” each refer to only A, only B, or only C; any combination of A, B, and C; and/or at least one of each of A, B, and C.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
P_device−P_patient=flowrate*(restrictor resistance)
where:
-
- V=velocity of fluid flow;
- D=the diameter of the flow restrictor conduit;
- Δp=energy loss (i.e. pressure change over a length L);
- L=length of flow restrictor; and
- μ=fluid viscosity.
where:
-
- Q=flow rate;
- R1=the radius of the
pin 506; - R2=the radius of the
tube segment 502; - G=the change in pressure over the length; and
- μ=fluid viscosity.
Claims (17)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/321,348 US11980736B2 (en) | 2020-05-26 | 2021-05-14 | Infusion pump flow rate control |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063030232P | 2020-05-26 | 2020-05-26 | |
US17/321,348 US11980736B2 (en) | 2020-05-26 | 2021-05-14 | Infusion pump flow rate control |
Publications (2)
Publication Number | Publication Date |
---|---|
US20210369956A1 US20210369956A1 (en) | 2021-12-02 |
US11980736B2 true US11980736B2 (en) | 2024-05-14 |
Family
ID=76808122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/321,348 Active 2042-03-30 US11980736B2 (en) | 2020-05-26 | 2021-05-14 | Infusion pump flow rate control |
Country Status (8)
Country | Link |
---|---|
US (1) | US11980736B2 (en) |
EP (1) | EP4157399A1 (en) |
JP (1) | JP2023529309A (en) |
CN (2) | CN113713206A (en) |
AU (1) | AU2021282091A1 (en) |
CA (1) | CA3179349A1 (en) |
MX (1) | MX2022014349A (en) |
WO (1) | WO2021242615A1 (en) |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5084021A (en) * | 1990-11-02 | 1992-01-28 | Baldwin Brian E | Patient controlled infusion apparatus and method |
US5167631A (en) * | 1991-09-17 | 1992-12-01 | Imed Corporation | Portable infusion device |
USD339193S (en) | 1991-09-18 | 1993-09-07 | Imed Corporation | Portable infusion pump |
US5290238A (en) * | 1992-06-10 | 1994-03-01 | Imed Corporation | Self priming tubing set for an infusion device |
US5356379A (en) | 1993-08-03 | 1994-10-18 | Vaillancourt Vincent L | Disposable ambulatory infusion pump assembly |
US5368570A (en) | 1991-11-12 | 1994-11-29 | Imed Corporation | Apparatus for infusing medical solutions |
US6562000B2 (en) | 2001-02-02 | 2003-05-13 | Medtronic, Inc. | Single-use therapeutic substance delivery device with infusion rate control |
US6595950B1 (en) | 2000-05-11 | 2003-07-22 | Zevex, Inc. | Apparatus and method for preventing free flow in an infusion line |
US6645183B2 (en) | 1999-09-22 | 2003-11-11 | Advanced Infusion, Inc. | Catheter with adjustable flow rate |
US20050245867A1 (en) | 2004-04-22 | 2005-11-03 | Olsen James M | Pressure relief methods in a medical catheter system |
US7341572B2 (en) * | 2003-02-28 | 2008-03-11 | Baxter International Inc. | Infusor with flexible sheath |
US7766860B2 (en) * | 2004-04-22 | 2010-08-03 | Medtronic, Inc. | Catheter systems having flow restrictors |
US7892213B2 (en) | 2007-04-20 | 2011-02-22 | Carefusion 303, Inc. | Fluid flow control system having capillary fluid flow restrictor |
US8323246B2 (en) * | 2008-01-02 | 2012-12-04 | The Regents Of The University Of Michigan | Dual drug delivery device |
WO2016140864A1 (en) | 2015-03-04 | 2016-09-09 | Repro-Med Systems, Inc. | Precision variable flow rate infusion system and method |
US10420886B2 (en) * | 2013-02-15 | 2019-09-24 | Repro-Med Systems, Inc. | Multi-flow universal tubing set |
-
2021
- 2021-05-14 US US17/321,348 patent/US11980736B2/en active Active
- 2021-05-20 AU AU2021282091A patent/AU2021282091A1/en active Pending
- 2021-05-20 CA CA3179349A patent/CA3179349A1/en active Pending
- 2021-05-20 JP JP2022572540A patent/JP2023529309A/en active Pending
- 2021-05-20 WO PCT/US2021/033483 patent/WO2021242615A1/en unknown
- 2021-05-20 MX MX2022014349A patent/MX2022014349A/en unknown
- 2021-05-20 EP EP21739191.1A patent/EP4157399A1/en active Pending
- 2021-05-26 CN CN202110577716.8A patent/CN113713206A/en active Pending
- 2021-05-26 CN CN202121146640.5U patent/CN216629322U/en active Active
Patent Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5084021A (en) * | 1990-11-02 | 1992-01-28 | Baldwin Brian E | Patient controlled infusion apparatus and method |
US5167631A (en) * | 1991-09-17 | 1992-12-01 | Imed Corporation | Portable infusion device |
AU640083B2 (en) | 1991-09-17 | 1993-08-12 | Carefusion 303, Inc. | Portable infusion device |
CA2068701C (en) | 1991-09-17 | 1995-01-03 | John Thompson | Portable infusion device |
USD339193S (en) | 1991-09-18 | 1993-09-07 | Imed Corporation | Portable infusion pump |
US5368570A (en) | 1991-11-12 | 1994-11-29 | Imed Corporation | Apparatus for infusing medical solutions |
US5290238A (en) * | 1992-06-10 | 1994-03-01 | Imed Corporation | Self priming tubing set for an infusion device |
AU654796B2 (en) | 1992-06-10 | 1994-11-17 | Imed Corporation | Self priming tubing set for an infusion device |
US5419770A (en) | 1992-06-10 | 1995-05-30 | Imed Corporation | Self priming tubing set for an infusion device |
US5356379A (en) | 1993-08-03 | 1994-10-18 | Vaillancourt Vincent L | Disposable ambulatory infusion pump assembly |
US6645183B2 (en) | 1999-09-22 | 2003-11-11 | Advanced Infusion, Inc. | Catheter with adjustable flow rate |
US6979311B2 (en) | 2000-05-11 | 2005-12-27 | Zevex, Inc. | Apparatus and method for preventing free flow in an infusion line |
US6685670B2 (en) | 2000-05-11 | 2004-02-03 | Zevex, Inc. | Apparatus and method for preventing free flow in an infusion line |
US6923785B2 (en) | 2000-05-11 | 2005-08-02 | Zevex, Inc. | Apparatus and method for preventing free flow in an infusion line |
US6595950B1 (en) | 2000-05-11 | 2003-07-22 | Zevex, Inc. | Apparatus and method for preventing free flow in an infusion line |
US6562000B2 (en) | 2001-02-02 | 2003-05-13 | Medtronic, Inc. | Single-use therapeutic substance delivery device with infusion rate control |
US7341572B2 (en) * | 2003-02-28 | 2008-03-11 | Baxter International Inc. | Infusor with flexible sheath |
US20050245867A1 (en) | 2004-04-22 | 2005-11-03 | Olsen James M | Pressure relief methods in a medical catheter system |
US7766860B2 (en) * | 2004-04-22 | 2010-08-03 | Medtronic, Inc. | Catheter systems having flow restrictors |
US7892213B2 (en) | 2007-04-20 | 2011-02-22 | Carefusion 303, Inc. | Fluid flow control system having capillary fluid flow restrictor |
US20110098673A1 (en) | 2007-04-20 | 2011-04-28 | Carefusion 303, Inc. | Fluid flow control system having capillary fluid flow restrictor |
US8323246B2 (en) * | 2008-01-02 | 2012-12-04 | The Regents Of The University Of Michigan | Dual drug delivery device |
US10420886B2 (en) * | 2013-02-15 | 2019-09-24 | Repro-Med Systems, Inc. | Multi-flow universal tubing set |
WO2016140864A1 (en) | 2015-03-04 | 2016-09-09 | Repro-Med Systems, Inc. | Precision variable flow rate infusion system and method |
Non-Patent Citations (2)
Title |
---|
International Search Report and Written Opinion for Application No. PCT/US2021/033483, dated Sep. 6, 2021, 15 pages. |
U.S. Government Accountability Office, "Medicare: CMS Should Evaluate Providing Coverage for Disposable Medical Devices That Could Substitute for Durable Medical Equipment", U.S. Government Accountability Office, GAO-17-600, Published Jul. 17, 2017, retrieved at https://www.gao.gov/products/gao-17-600. |
Also Published As
Publication number | Publication date |
---|---|
JP2023529309A (en) | 2023-07-10 |
CA3179349A1 (en) | 2021-12-02 |
CN216629322U (en) | 2022-05-31 |
WO2021242615A1 (en) | 2021-12-02 |
AU2021282091A1 (en) | 2022-12-22 |
US20210369956A1 (en) | 2021-12-02 |
EP4157399A1 (en) | 2023-04-05 |
CN113713206A (en) | 2021-11-30 |
MX2022014349A (en) | 2022-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5167631A (en) | Portable infusion device | |
CN101380492B (en) | Device for administering of medication in fluid form | |
US8377043B2 (en) | Fluid delivery apparatus with bellows reservoir | |
EP2608823B1 (en) | Infusion control device | |
EP1702635B1 (en) | Transcutaneous delivery means | |
EP1513573B1 (en) | Plunger assembly for patient infusion device | |
US7892213B2 (en) | Fluid flow control system having capillary fluid flow restrictor | |
US20170035962A1 (en) | Infusion system and methods | |
US20070066939A1 (en) | Electrokinetic Infusion Pump System | |
CN107921201B (en) | Device for infusing fluid | |
AU2019283854B2 (en) | Intravenous tubing set modified for in-line catheter flushing | |
US20060229558A1 (en) | Medical infuser device | |
US20050267422A1 (en) | Fluid delivery apparatus | |
JP2023158007A (en) | Pressure spike absorbing systems | |
US11980736B2 (en) | Infusion pump flow rate control | |
CN107249668B (en) | Micro-infusion device for drug delivery | |
AU2015402759B2 (en) | Shaped elastomeric infusion pump | |
CN107029317B (en) | Medicine injector | |
JPH07222798A (en) | Transfusion set and medicinal liquid injecting device using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
AS | Assignment |
Owner name: CAREFUSION 303, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FRANKS, BRETT;REEL/FRAME:056666/0506 Effective date: 20210514 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
ZAAB | Notice of allowance mailed |
Free format text: ORIGINAL CODE: MN/=. |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: AWAITING TC RESP., ISSUE FEE NOT PAID |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |